SMAD2 and neoplasm: As uncovered by our results, the maintenance of p27 expression in hPSCs via SMAD2/3-NANOG-OCT4 is particularly interesting considering the dual role of p27 as a tumor suppressor as well as an oncogene (Besson et al., 2007).